Kevin D Amour Brooklyn Immuno Therapeutics, Inc. (BTX) insider trading activity

BTX Quotes by TradingView

Kevin D Amour is Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc.. Currently has a direct ownership of 11,496 shares of BTX, which is worth approximately $0. The most recent transaction as insider was on Jun 28, 2022, when has been sold 6,077 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $3,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.5K
0% 3M change
0% 12M change
Total Value Held $0

Kevin DAmour Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2022
SELL
Payment of exercise price or tax liability
$3,342 $0.55 p/Share
6,077 Reduced 34.58%
11,496 Common Stock
Jun 28 2022
BUY
Exercise of conversion of derivative security
-
17,573 Added 50.0%
17,573 Common Stock
KD

Kevin D Amour

Chief Scientific Officer
Brooklyn, NY

Track Institutional and Insider Activities on BTX

Follow Brooklyn ImmunoTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTX shares.

Notify only if

Insider Trading

Get notified when an Brooklyn Immuno Therapeutics, Inc. insider buys or sells BTX shares.

Notify only if

News

Receive news related to Brooklyn ImmunoTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTX